 |
Contact
Work with us Our AD biomarker assays represent unique product development opportunities for drug or diagnostic companies in all phases of AD product and market development, from preclinical and clinical development to marketed products. If you believe that your development programs would benefit from our technologies, we would be happy to discuss working with you on a fee-for-services basis or under a licensing arrangement, as part of a wider development partnership. Please contact us to learn how our technologies could benefit your development project or to discuss other opportunities.
For all other enquiries, please contact our Head Office by filling in the Enquiry Form.
|
For business development enquiries:
Europe, Middle East, Africa and Asia Richard Hadden, CEO 54, St. John’s Square London EC1V 4JL UK T: +44 20 7250 4210 F: +44 20 7250 4211
North & South America, Australasia Tim Tankosic, MD c/o New Medicine Inc P.O. Box 2185 Venice, CA 90294 USA T: +1 310 751 6463 M: +1 310 403 3111
To e-mail us, use: firstname.lastname@ cytoxgroup.com
|